The earnings call highlighted significant challenges faced by Bioceres Crop Solutions, particularly in Argentina, leading to a substantial decline in revenues and EBITDA. However, the company demonstrated strong cash flow generation and international sales growth, supported by cost-saving initiatives, suggesting potential stabilization and recovery in the future.
Company Guidance
During the Bioceres Crop Solutions fiscal fourth quarter and full year 2025 earnings call, CEO Federico Trucco and Head of Investor Relations Paula Savanti provided key guidance metrics amidst a challenging year. The company reported a 40% decline in fourth-quarter revenues to $74.7 million, primarily due to a $25 million reduction in seed sales, with further declines in crop nutrition and crop protection. For the full fiscal year, revenues were down 28% to $335.3 million, with a consistent decrease across all segments. The gross profit for the quarter fell 47% to $25.4 million, driven by lower margins in the Crop Nutrition and Seeds segments. Despite these challenges, Bioceres focused on cash generation, achieving a 27% year-over-year increase in operating cash flow to $53 million. The company also emphasized a reduction in operating expenses by 10% to 12% and a decrease in CapEx and R&D investments by 50%, aiming for an EBITDA margin of 22% and a gross margin of 40% in future periods. The net financial debt stood at $220.8 million, with a net debt to adjusted EBITDA ratio of 7.8x. Looking forward, Bioceres aims to stabilize its financial position and leverage its biological initiatives and strategic partnerships to drive growth in less volatile agricultural markets.
Strong Cash Flow Generation
Despite profitability pressures, operating cash flow reached $29.9 million in the fourth quarter, up 28% year-over-year. For the full fiscal year, operating cash flow was $53 million, a 27% increase versus last year.
International Sales Growth
International sales of some core technologies grew strongly in the quarter, with adjuvant sales in Brazil almost doubling and bioprotection products in the U.S. growing almost 40%.
Cost Control Measures
The company achieved $5.7 million in savings in operating expenses due to cost control measures and plans to continue these efforts to achieve 10%-12% savings in operating expenses.
Bioceres Crop Solutions (BIOX) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BIOX Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Sep 09, 2025
$2.67
$2.24
-16.10%
May 21, 2025
$4.65
$4.45
-4.30%
Feb 11, 2025
$5.55
$4.78
-13.87%
Nov 12, 2024
$6.48
$6.66
+2.78%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Bioceres Crop Solutions (BIOX) report earnings?
Bioceres Crop Solutions (BIOX) is schdueled to report earning on Nov 12, 2025, Before Open (Confirmed).
What is Bioceres Crop Solutions (BIOX) earnings time?
Bioceres Crop Solutions (BIOX) earnings time is at Nov 12, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.